In-Depth: San Diego company developing nasal drops to treat COVID

Sorrento Therapeutics announced the results of lab tests showing that one of its antibodies far exceeds the viral blocking power of any currently authorized antibody treatment against omicron. The company plans to incorporate the drug in nasal drops.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting